Remimazolam NeuroImaging Trial
EARLY_PHASE1
60
about 1.8 years
18–59
1 site in PA
About this study
Researchers are testing the effects of remimazolam on brain activity and connectivity. Participants will undergo functional MRI scans while at rest, during nerve stimulation, and when learning new memories. The trial will last for 641 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Remimazolam
- 2.Use Peripheral Nerve Stimulation
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
remimazolam
injection, intravenous
Primary: subjective pain ratings
Secondary: functional magnetic resonance imaging activation of memory encoding task, functional magnetic resonance imaging activation of the response to noxious stimulation
therapeutic